Dublin, April 17, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Infusion Pumps and Devices: Technologies and Global Markets" report to their offering.
The global market for infusion pumps and devices reached $18.5 billion in 2015. The market should reach $19.6 billion in 2016 and nearly $25.8 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.6% from 2016 to 2021.
This report focuses on the global market of infusion devices and applications as medical equipment. This report focuses on the global market of infusion pumps and devices, providing an updated review including basic design and its applications in various arenas of biomedical and healthcare sectors. The report covers the total market, which includes two broad categories: general infusion pumps and devices, and specialty infusion pumps and devices.
General pumps and devices are categorized into large volume infusion pumps, ambulatory and disposable pumps, syringe infusion and chemotherapy pumps. Specialty pumps are categorized as enteral, patient-controlled analgesics (PCA), insulin pumps and implantable pumps. The report also covers the market for infusion devices by the end user, with emphasis on the usage of infusion pumps and devices in therapeutic categories and various disease sectors.
The end users for infusion devices considered in the report are diabetes, anesthesia and analgesia, oncology and blood disorders, nutrition, other applications such as treatment of diseases like congestive heart failure, Parkinson's disease, hemophilia and immune deficiencies.
The key market players include Animas Corp., Baxter International, B. Braun Melsungen AG, Fresenius Kabi AG, I-Flow Corp., Hospira Inc., Insulet Corp., Medtronic, Moog Inc. and Smiths Medical.
Key Topics Covered:
1: Introduction
- Study Objectives
- Reasons For Doing This Study
- Contributions Of The Study And For Whom
- Scope Of The Study
- Methodology
- Information Sources
2: Executive Summary - Complimentary
3: Overview
- Definitions
- Introduction
- Advantages And Disadvantages Of Infusion Devices
- History Of Infusion Pumps And Devices
- Classification Of Infusion Pumps And Devices
- Infusion Pump Associated Hazards And Problems
- Future Of Infusion Pumps And Devices
4: Regulatory Aspects
- New Products Approved From 2013 To 2016
- Fda Recalls And Safety Alerts
5: New Developments
- New Products And Developments
- Awards For Infusion Pumps And Devices
6: Market Analysis
- Market By Type
- Market By Region
7: Industry Structure
- General Infusion Pumps And Devices
- Specialty Infusion Pumps And Devices
8: Market By Application
- Market By Application Of Global Infusion Pumps And Devices
- General Infusion Pumps And Devices
- Specialty Infusion Pumps And Devices
9: Patent Analysis
- Patents By Year
- Patents By Type
- Patents By Company
- Patents By Country
- Patents By Assignee
10: Current Situation
- Factors Affecting The Infusion Pumps And Devices Market
- Mergers And Acquisitions: Future Perspective
11: Company Profiles
- Animas Corp.
- Baxter International
- B. Braun Melsungen AG
- BD Biosciences
- Carefusion
- Cequr S.A.
- Codman & Shurtleff Inc.
- Covidien Plc
- Debiotech
- Flowonix Medical Inc.
- Fresenius Kabi Ag
- Halyard Health Inc.
- Hospira Inc.
- I-Flow Corp.
- Insulet Corp.
- Intrapump Infusion Systems
- Iradimed Corp.
- Medtronic Inc.
- Micrel Medical Devices
- MOOG Inc.
- Nipro Corp.
- Novo Nordisk A/S
- Pfizer Inc.
- Smiths Medical
- Sooil Development
- Summit Medical Products Inc.
- Tandem Diabetes Care Inc.
- Terumo Corp.
- Valeritas Inc.
- Zyno Medical Llc
12: Appendix I-Abbreviations
For more information about this report visit http://www.researchandmarkets.com/research/bj4v52/infusion_pumps